GLP-1 agonists have shown promise in treating insulin resistance and improving fertility in patients. However, the effects of these drugs on pregnancy are still unknown and patients should discuss any plans for becoming pregnant with their doctors and consider contraceptive strategies.
Luba Yammine, an addiction researcher, suggests that the part of the brain responsible for food cravings may also play a role in cravings for substances of abuse. As drugs like Ozempic and Mounjaro have become more prevalent, patients have reported unexpected side effects such as reduced desire to smoke or drink. Further research is needed to understand the connection between these drugs and addiction.
In the medical field, GLP-1 drugs have shown promise as potential anti-addiction medications. Christian Hendershot, an addiction researcher, notes that there are limited medications available for treating addiction, and patients often struggle to access them. Additionally, addiction research receives less funding compared to other diseases.